Christina Baik

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 9

Top Topics

Prognostic Factors

Small Cell Lung Cancer

Top Venues

Advances in therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Christina Baik, Michael L Cheng, Martin Dietrich, Jhanelle E Gray, Nagla Abdel Karim
Correction to: A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600EMutant Metastatic Non-Small Cell Lung Cancer. Advances in therapy (2024)
Christina Baik, Michael L Cheng, Martin Dietrich, Jhanelle E Gray, Nagla Abdel Karim
A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer. Advances in therapy (2024)
Christina Baik, Michael L Cheng, Martin Dietrich, Jhanelle E Gray, Nagla Abdel Karim
A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer. Advances in therapy (2024)
Christina Baik, Michael L Cheng, Martin Dietrich, Jhanelle E Gray, Nagla Abdel Karim
Correction to: A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600EMutant Metastatic Non-Small Cell Lung Cancer. Advances in therapy (2024)
Christina Baik, Michael L Cheng, Martin Dietrich, Jhanelle E Gray, Nagla Abdel Karim
A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer. Advances in therapy 41 (7) (2024)
Christina Baik, Michael L Cheng, Martin Dietrich, Jhanelle E Gray, Nagla Abdel Karim
A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer. Advances in therapy 41 (7) (2024)
Christina Baik, Michael L Cheng, Martin Dietrich, Jhanelle E Gray, Nagla Abdel Karim
A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer. Advances in therapy 41 (7) (2024)
Christina Baik, Michael L Cheng, Martin Dietrich, Jhanelle E Gray, Nagla Abdel Karim
A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer. Advances in therapy 41 (7) (2024)
Christina Baik, Michael L Cheng, Martin Dietrich, Jhanelle E Gray, Nagla Abdel Karim
A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer. Advances in therapy (2024)